Moreover, the increased morbidity and mortality in patients with NASH is known to be closely related to the severity of liver fibrosis
Both immunoreactive gut glucagon and L-cells are present most abundantly in the distal small intestine and colon (31, 62)
How long do the effects of GLP-1 drugs last
Michael Baumholtz
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia
Back Deacon, DF, Johnsen, AH, Holst, JJ (March 1995) 'Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo', Journal Clinical Endocrinology Metabolism , 80/3, 952-7